Follitropin delta in a long hormone-suppression IVF cycle
Part of Women’s health & pregnancy clinical trials.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 44 years old.
- You must have had an AMH blood test in the last year showing a result between 0.3 and 4.9 ng/ml.
- This must be your first or second try at IVF or ICSI using sperm from a partner or donor.
- You cannot have taken birth control pills (with estrogen and progestin) in the past month.
- You cannot have PCOS that causes irregular ovulation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This trial is studying whether a specific fertility medication (hMG) helps improve embryo quality during IVF when you are also doing genetic testing of embryos. It may help you have better embryos for transfer.
This trial tests two different starting doses of a fertility drug (follicle-stimulating hormone, or FSH) during a specific IVF preparation method called PPOS. The goal is to see which dose leads to better egg development for women with good fertility prospects.
This study tests whether adding a hormone called r-hLH to standard IVF treatment helps women aged 35 to 40 produce better eggs and improve their chances of pregnancy. It is for women who are on their first or second cycle of assisted reproduction.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
Hear when a new Infertility (IVF Patients) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.